Analysts at Leerink Swann upgraded Boston Scientific stock from “market perform” to “outperform.” Leerink Swann has an $18 price target on the company’s stock, according to a WKRB News & Analysis report.
Boston Scientific disclosed insider trading activity — David A. Pierce, senior vice president and president, endoscopy of Boston Scientific unloaded 5,000 shares at an average price of $12.90.
EndoChoice fulfilled customer orders for its newly-released second generation Fuse system.
Medigus has been awarded a Japanese patent for its miniature camera — the micro ScoutCam.
Pharmaceutical company Roche received FDA approval for the cobas TaqScreen MPX Test, v2.0. The test can be used in the detection and identification of HIV, Hepatitis C virus and Hepatitis B virus in human blood.
In the wake of its AbbVie deal fall through, Shire has agreed to acquire NPS Pharmaceuticals, according to a report by The New York Times.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
GI physician social media preferences: Facebook vs. Twitter
7 New Year’s resolutions from the AGA
Dr. Michelle Inkster named Professional Woman of the Year
